Objectives This study intended to compare outcomes between transradial (TR) and transfemoral (TF) percutaneous revascularization in high-risk coronary anatomy.
Compared with transfemoral (TF) vascular access, transradial (TR) percutaneous coronary intervention (PCI) is associated with clinically significant reductions in procedural-related bleeding complications and improved patient satisfaction (1) (2) (3) (4) (5) (6) (7) (8) (9) , yet its adoption has remained a limited procedure in many geographies. In part related to operator inexperience (10 -12) , increasing performance of TR PCI is also challenged by an incomplete evidence basis, furthering perceptions that the practicality of TR PCI may be restricted to less complex coronary anatomy and lower risk clinical settings.
Unprotected left main coronary artery (UPLM) disease represents a particularly challenging lesion subset for percutaneous coronary revascularization. Despite an evolving evidence basis and guideline recommendations supporting the relative safety and efficacy of UPLM PCI compared with surgical revascularization (13, 14) , technical complexities related to stent technique and bifurcation disease represent unresolved procedural-related dilemmas for interventionalists. Considering the practical limitations associated with TR PCI in high-risk lesion anatomy (e.g., guiding catheter support, equipment size restrictions), UPLM disease challenges the feasibility of a transradial procedural strategy compared with a more standard femoral approach. Our purpose, therefore, was to compare procedural results, resource use, and clinical outcomes between TR and TF methods of percutaneous coronary revascularization with drug-eluting stents (DES) for UPLM disease.
Methods

Study population. Between April 2004 and April 2009
, consecutive patients undergoing UPLM PCI with DES at the Fu Wai Hospital in Beijing, China, were evaluated for in-hospital and late-term outcomes. Unprotected left main coronary disease was defined as documented myocardial ischemia with Ն50% UPLM stenosis and no patent bypass graft to the left anterior descending or left circumflex arteries. In general, the decision for UPLM PCI was based on consultation with both patients and surgeons in the setting of isolated UPLM disease or in situations of multilesion treatment amenable to complete revascularization with stent placement. For those patients with UPLM stenosis and more complex multivessel disease, PCI was elected in instances of patient refusal for surgery or comorbidity that posed excessive surgical risk. Patients were excluded from the present analysis in instances of contraindication for antiplatelet therapy, acute myocardial infarction (MI) within 7 days, or bailout stenting of the left main artery due to PCI-related complications (e.g., dissection, thrombus) of non-left main target lesions. Procedural details. Vascular access method and stent technique were performed according to the operator's discretion. Ostial or shaft lesions without distal bifurcation involvement were typically treated with a single stent. Stent strategies to treat distal bifurcation lesions included: crossover stenting with side branch balloon angioplasty, provisional or dedicated T stenting, simultaneous kissing or V stenting (TF approach only), Culotte or crush technique (including "step crush" technique involving sequential balloon crushing of side branch stent followed by main vessel stenting). Final kissing balloon post-dilation was performed in cases with suboptimal results after crossover stenting at the side branch ostium and, in most cases, with 2-stent implantation. Intravascular ultrasound (IVUS)-guided stenting was encouraged to achieve optimal stent expansion and lesion coverage. Stent type and brand were selected per the treating physician's discretion among those commercially available at the time of the study, namely, the sirolimus-eluting Cypher stent (Cordis, Europa N.V., LJ Roden, the Netherlands), paclitaxel-eluting Taxus stent (Boston Scientific, Galway, Ireland), sirolimus-eluting Firebird stent (MicroPort, Shanghai, China), and sirolimuseluting Excel stent (JW Medical Co., Ltd., Shandong, China). Before the procedure, all patients received aspirin, 300 mg daily, and a 300-mg loading dose of clopidogrel was given at least 1 day before the procedure. During the procedure, unfractionated heparin (100 U/kg) was administered to all patients, and use of glycoprotein IIb/IIIa inhibitors was per the operator's judgment. After the procedure, aspirin was prescribed at a dose of 300 mg daily for 3 months, followed by 100 mg daily indefinitely; clopidogrel 75 mg daily was prescribed for at least 1 year. Patient follow-up. All patients were evaluated by clinic visit or by phone at 1, 3, 6, and 12 months and annually thereafter. Per local standards, all patients were advised to return for coronary angiography 6 months following the index procedure, or earlier if clinically indicated by symptoms or documentation of myocardial ischemia. Two independent, experienced staff members analyzed all baseline and follow-up angiographic results. Quantitative coronary angiography analysis was performed with QUANTCOR QCA (CAAS II) Version 5.0 (Pie Medical Imaging, Maastricht, the Netherlands). Binary restenosis was defined as Ն50% diameter stenosis at follow-up and was classified as in-stent or in-segment if located within 5 mm proximal or distal to the stent margin. Study end points. Angiographic success was defined as a residual stenosis of Ͻ30% by visual estimation in the presence of Thrombosis In Myocardial Infarction (TIMI) flow grade 3. Procedural success was defined as achievement of TIMI flow grade 3 with a final residual stenosis of Ͻ30% without in-hospital death, MI, or emergency coronary artery bypass surgery. Myocardial infarction was diagnosed by electrocardiographic changes and/or a rise and fall of creatine kinase-myocardial band fraction in the presence of ischemic symptoms. New development of pathological Q waves in 2 contiguous leads was defined as Q-wave MI; and in the absence of pathological Q waves, an elevation in creatine kinase-myocardial band level Ͼ2 times the upper limit of normal was defined as non-Q-wave MI. Target vessel revascularization (TVR) was determined as any repeated PCI or bypass grafting surgery to treat a luminal renarrowing in-stent or within 5-mm borders adjacent to the stent, including the ostia of the left coronary arteries. Death that could not be attributed to a noncardiac etiology was considered cardiovascular death. Major adverse cardiac events (MACE) was defined as the occurrence of cardiovascular death, nonfatal MI, and TVR in hospital and during follow-up. Stent thrombosis was adjudicated according to Academic Research Consortium definitions as definite, probable, and possible classifications (15) . Bleeding events were evaluated during hospitalization and characterized according to TIMI (major, minor) and GUSTO (Global Use of Strategies to Open Coronary Arteries) (moderate, severe) study criteria in addition to any reported bleeding (16, 17) . Statistical analysis. Patient demographics, including baseline clinical, angiographic, and procedural characteristics from TR and TF groups were described using means for continuous variables and frequencies for categorical variables. Proportions were compared between groups using chi-square analysis and Fisher exact test where appropriate. Group means were compared using Student t test. Cumulative event rates were estimated by the Kaplan-Meier method and tested by the log-rank statistic. Differences in the incidence rates of individual clinical outcomes and composite outcomes between patients undergoing the 2 procedures were investigated by developing multivariable Cox proportional hazards models after confirming that the proportional hazards assumption was met. Adjusted relative risks were estimated with the potential confounders entered as covariates.
Because the choice of procedure was not randomized, a 1:1 matched propensity score analysis was performed to minimize bias. The transradial patients were ordered and sequentially matched to the nearest unmatched transfemoral patients according to the estimated propensity score. Propensity scores were calculated using the following baseline variables as predictors: sex, age, prior MI, prior PCI, previous coronary artery bypass surgery, diabetes mellitus, unstable angina, lesion complexity (class B2/C), left main bifurcation lesion, pre-dilation angioplasty, sirolimuseluting stent treatment, stent diameter, stent length, use of intravascular ultrasound, post-dilation angioplasty, and treatment with intra-aortic balloon counterpulsation. If the difference of the estimated propensity score between transradial and transfemoral group is Յ0.001, then these 2 patents were eligible for matching. Paired t tests for continuous variables or McNemar test for categorical variables were used for comparison within the matched pairs. Kaplan-Meier curves also were constructed for study outcomes in the matched cohort. Matched Cox regression analysis was employed to determine the effect of 2 procedures on clinical outcomes. Matched Cox regression analysis is a stratified analysis that uses each pair of matched patients as a separate stratum to compare survival within each pair, which is then used to estimate the overall hazard ratio. All analyses were conducted using SAS software, version 9.13 (SAS Institute, Cary, North Carolina), and a 2-sided p value of 0.05 or less was considered to indicate statistical significance. Data represented as n (%) or mean Ϯ SD. *Defined as requiring medical therapy.
Results
Among
LM ϭ left main; MI ϭ myocardial infarction; PCI ϭ percutaneous coronary intervention;
UPLM ϭ unprotected left main. Table 1 . Overall, patients in the TF group were older (61 Ϯ 11 vs. 59 Ϯ 11 years, p ϭ 0.02) and more frequently presented with unstable angina (49% vs. 37%, p Ͻ 0.01). Approximately one-fourth of patients in each cohort were diabetic. Although there were no differences regarding multivessel coronary disease, left main bifurcation disease was significantly more common in the TF group than with TR patients. Most patients received treatment with sirolimuseluting stents (77% overall; 75% TR, 79% TF, p ϭ 0.11 for comparison).
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Overall stent length and number of lesions treated did not statistically differ between TR and TF groups ( Table 2) . Specific to the left main target lesion, stent length was also similar, yet a TF approach was more commonly associated with performance of bifurcation stenting (38% vs. 19%, p Ͻ 0.01) and larger guiding catheter caliber. For TR patients receiving 2 stents for UPLM PCI (19%, 67 patients), bifurcation stent technique included stepped crush (72%), T stenting (22%) and Culotte (6%). Among TF bifurcation cases treated with a 2-stent technique (178 patients, 38%), strategies were crush (60%), T stenting (17%), kissing or V stenting (16%) and Culotte (7%)
Clinical and angiographic outcomes. During hospitalization, no differences were observed in the rates of cardiovascular death, MI, TVR, or composite end points (Table 3) . However, hospital stay duration was significantly shorter among TR PCI patients (days: 8.5 Ϯ 5.9 vs. 9.9 Ϯ 5.9, p ϭ 0.001), a difference driven by decreased hospitalization time post-revascularization (days: 4.5 Ϯ 4.0 vs. 5.1 Ϯ 3.4, p ϭ 0.01).
In-hospital bleeding events were significantly lower with TR PCI compared with a TF approach. Specifically, the combined occurrence of TIMI major and minor bleeding was 0.6% and 2.8% in the TR and TF groups, respectively (p ϭ 0.02). A vascular closure device was employed in 191 Data represented as n (%) or mean Ϯ SD.
MACE ϭ major adverse cardiac events; TVR ϭ target vessel revascularization; other abbreviations as in Table 1 . Data represented as n (%) or mean Ϯ SD.
DES ϭ drug-eluting stent(s); IABP ϭ intra-aortic balloon pump; IVUS ϭ intravascular ultrasound; other abbreviations as in Table 1 .
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Yang et al. Clinical follow-up was complete for all patients over an average 17-month duration, although the follow-up period was longer for TF patients (587 Ϯ 343 days vs. 442 Ϯ 267 days, p Ͻ 0.01). Compared with TF patients, there were no significant differences in rates of MACE (10.2% TF vs. 9.2% TR, p ϭ 0.63), or the individual component end points (Fig. 1, Table 3 ). Specifically, rates of left mainspecific TVR (5.8% TF vs. 5.7% TR, p ϭ 0.95) and any TVR (7.5% TF vs. 7.9% TR, p ϭ 0.89) were similar between treatment groups. Definite and probable stent thrombosis were also similar overall and at differing time intervals (early, late, very late) between TR and TF groups (1.1% TR vs. 2.6% TF, p ϭ 0.13; Table 3 ).
Using logistic regression to derive the propensity score model, 254 matched patient pairs were compared. Following adjustment, only the baseline variable of prior coronary artery bypass graft remained statistically significant. The C-statistic for the model was 0.70. In this adjusted model, there were no significant differences throughout the follow-up period in adverse event rates; outcomes of cardiovascular death (1.2% vs. 2.0%, p ϭ 0.48), nonfatal MI (4.7% vs. 2.4%, p ϭ 0.16), stent thrombosis (0.8% vs. 2.8%, p ϭ 0.10), and any target TVR (6.0% vs. 6.7%, p ϭ 0.72) did not statistically differ among TR and TF groups, respectively. Further, in a multivariate regression analysis, TR method of PCI was not predictive of adverse cardiac events (Fig. 2) .
At 6 months, angiographic surveillance was performed in 100 (28.3%) TR patients and 264 (56.4%) TF patients (p Ͻ 0.01 for comparison). For left main lesions, neither in-stent (8.0% TR vs. 12.5% TF, p ϭ 0.27) nor in-segment (9.0% TR vs. 14.0% TF, p ϭ 0.22) restenosis rates differed between treatment methods. For both TR and TF groups, restenosis most commonly occurred at the ostium of the left circumflex artery (5.0% TR vs. 11.0% TF, p ϭ 0.11).
Discussion
Through comparison of procedural and clinical outcomes with TF vascular access, these findings extend our understanding of TR PCI to more complex coronary anatomy and high-risk clinical settings. The salient findings of this study are: 1) UPLM PCI, including treatment of distal left main bifurcation disease, is feasible by the TR method and is associated with high procedural success; 2) bleeding events are significantly less common with UPLM TR PCI compared with a TF approach; 3) UPLM TR PCI is associated with shorter hospital stay duration; and 4) compared with a TF approach and following propensity score adjustment, TR PCI for UPLM disease is associated with similar early and late outcomes of major cardiovascular events.
To our knowledge, this study represents the largest survey of TR PCI for UPLM disease and the only comparative report of vascular access methods for UPLM PCI. Whereas several studies have demonstrated the superiority of TR vascular access over a TF approach for reductions in vascular access and bleeding complications (1-9,18 -21) , expansion of TR PCI to more complex and high-risk lesion anatomy has been restricted by operator inexperience and lack of supportive evidence. This perception is especially relevant for UPLM disease, considering the technical challenges of guiding catheter support, limitations of catheter size and oftentimes simultaneous need for multiple angioplasty catheters, and consequences of procedural failure.
Limitations regarding guiding catheter size and design and equipment constraints notwithstanding, procedural success rates and duration were similar between vascular access methods, demonstrating the feasibility of complex percutaneous coronary revascularization by a TR approach. Specifically, TR PCI with 6-F guiding catheters was associated with near uniform procedural success despite the simultaneous requirement of multiple catheters and guidewires, and compared with a TF approach, did not increase fluoroscopy time and overall procedural duration. Several modest-sized randomized and observational trials have compared procedural outcomes (including contrast use and fluoroscopy time) between radial and femoral access methods with variable results (6 -8,20 -22) . In a systematic overview of 12 randomized trials comparing the radial and femoral approach for diagnostic and interventional procedures, a significant reduction in vascular access complications with the radial approach (odds ratio [OR]: 0.20; 95% confidence interval [CI]: 0.09 to 0.42) was reported despite a higher likelihood of procedural failure compared with femoral access (OR: 3.30; 95% CI: 1.63 to 6.71) (8) . Although this relative reduction in bleeding complications was similar to that observed in this evaluation, the procedural efficacy observed in the present study is consistent with more contemporary trials that have described no differences in procedural failure between treatment strategies (6, 7, 21) and fewer access site-related complications (6, 7, 20, 21) , likely reflecting advances in operator experience, technique, and technology that also include vasodilator pharmacology and hydrophilic catheters. In our center, 353 UPLM percutaneous revascularization procedures were performed by the TR approach (accounting for 43% of total UPLM cases) in a setting of skilled operators using TR PCI in more than 80% of all PCI cases.
A radial artery approach for transcatheter coronary procedures is supported by the consistency across comparative trials demonstrating reductions in bleeding complications and need for blood product transfusion compared with femoral access (4,5,7,18,19 ). In parallel with these studies Multivariable matched propensity analysis demonstrates no statistically significant differences in the incidence rates of individual and composite clinical outcomes between transradial and transfemoral percutaneous coronary intervention cohorts. Abbreviations as in Figure 1 . N T I O N S , V O L . 3 , N O . 1 0 , 2 0 1 0   O C T O B E R 2 0 1 0 : 1 0 3 5 -4 2 Yang et al. Transradial Left Main Revascularization comparing vascular access methods, TR PCI was associated with significantly fewer bleeding complications than were directionally consistent across standardized bleeding criteria. Although not statistically significant between strategies, femoral access complications (e.g., pseudoaneurysm, arteriovenous fistula) were numerically more common in the TF cohort, with none observed in the TR cohort. Although this analysis may not directly correlate prolonged hospitalization in the TF group with bleeding events or vascular access complications, the higher frequency of bleeding in the absence of other differential outcomes is suggestive. In particular, differences in hospital stay were principally driven by shorter post-procedural hospitalization for patients treated with the TR method. Aside from potential direct cost-savings related to avoidance of vascular and bleeding complications (23, 24) , a TR approach may also reduce hospital expenses through decreased resource use and abbreviated length of hospitalization (3, 9, 25) .
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Both early and late clinical outcomes for each group in this study were consistent with other large observational analyses of patients undergoing UPLM PCI (15) . Favorable outcomes may in part be attributed to technique (26, 27) , including high stent deployment pressure, kissing balloon post-dilation, and use of IVUS guidance (28), which are not excluded by a TR approach. Alternatively, despite differences in in-hospital bleeding events, late-term outcomes did not statistically differ according to vascular access method. Perhaps representing limitations in sample size and study design, this observation differs from larger comparative studies that have established the relationship between the TR PCI, reduced major bleeding and/or transfusion, and decreased early and late-term mortality (5, 18) . Study limitations. Despite propensity score adjustment, comparisons from this analysis are limited by their retrospective and nonrandomized design in which operator bias and unmeasured confounders may preclude any definite conclusion. Nevertheless, most clinically relevant patient demographics did not statistically differ between TR and TF groups, except for prevalence of distal bifurcation disease. Even in this latter instance, TR patients were more commonly treated with a single stent technique that may be associated with a more favorable outcome compared with 2-stent procedures (26, 27) . However, consistent with previous non-left main bifurcation strategy trials (29) and compared with prior comparative vascular access trials reporting greater fluoroscopy time with radial artery catheterization (6, 22) , a higher prevalence of single stent bifurcation procedures and overall lower incidence of bifurcation disease may also in part explain lower fluoroscopy time and contrast volume use in the TR group. Similarly, although study population size and operator selection of vascular access may mitigate potential differences in low-frequency late clinical events between treatment groups, adverse event rates were very similar, if not lower (bleeding, in particular) with the TR method, representing a potential negative bias against TR PCI. Further, radial artery access was not identified as a predictor of adverse outcome in multivariable regression analysis. Finally, the observations of abbreviated hospital duration and decreased procedural-related time and provisions with TR PCI must be cautiously interpreted given that these patients demonstrated somewhat lower clinical, angiographic, and procedural complexity factorsall of which may influence length of hospitalization and resource use.
Conclusions
Compared with a TF approach, TR percutaneous coronary revascularization for UPLM disease is feasible and associated with similar procedural success, abbreviated hospitalization, reduced bleeding, and comparable late-term clinical safety and efficacy. These results not only inform our understanding of TR PCI regarding the procedural challenges involved in the treatment of more complex and high-risk coronary anatomy, but also add to the evidence basis associating TR PCI with reduced bleeding events and resource use.
